| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 32,543 | 33,696 | 35,113 | 34,913 | | Cost of Revenue | 8,684 | 10,030 | 12,155 | 13,769 | | | Gross Profit |
-
| 23,666 | 22,958 | 21,144 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 15,214 | 17,582 | 15,581 | 16,098 | | Non Recurring |
-
|
-
|
-
|
-
| | Others | 8,444 | 9,537 | 8,058 | 20,182 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss |
-
| (3,453) | (681) | (15,136) | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
|
-
|
-
| | Earnings Before Interest And Taxes | 201 | (3,453) | (681) | (15,136) | | Interest Expense | 526 | 531 | 494 | 817 | | Income Before Tax | (325) | (3,984) | (1,175) | (15,953) | | Income Tax Expense | (198) | (1,290) | (539) | (5,557) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (127) | (2,694) | (636) | (10,396) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (127) | (2,694) | (636) | (10,396) | | Preferred Stock And Other Adjustments | (664) | (665) | (589) | (328) | | | Net Income Applicable To Common Shares | ($791) | ($3,359) | ($1,225) | ($10,724) |
|
0.11% Nasdaq 
0.41 (5.55%) 
Income Statement
